The recombinant therapeutic protein market is anticipated to grow at a significant CAGR of 6.4% during the forecast period (2022-2028). Therapeutic proteins are laboratory-engineered proteins with medicinal use. Insulin was the first therapeutic protein, developed in 1920 to treat diabetes. Recombinant DNA technology makes it simple to generate proteins in certain host cells such as […]
